We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.24%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.46B
AUM Growth
-$25.5M
Cap. Flow
-$13.6M
Cap. Flow %
-0.93%
Top 10 Hldgs %
23.16%
Holding
4,911
New
1,154
Increased
1,500
Reduced
1,460
Closed
679

Sector Composition

Rank Sector Weight
1 Technology 9.13%
2 Financials 8.46%
3 Industrials 5.89%
4 Healthcare 5.51%
5 Consumer Discretionary 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OFED
4651
DELISTED
Oconee Federal Financial Corp.
OFED
-625
Closed -$14K
BBIG
4652
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
-97
Closed -$3K
NMTR
4653
DELISTED
9 Meters Biopharma
NMTR
-130
Closed -$3K
ARDS
4654
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
-38
Closed
ISEE
4655
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$0 ﹤0.01%
+153
New +$178
IMBI
4656
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$0 ﹤0.01%
20
NIQ
4657
DELISTED
NUVEEN INTERMEDIATE DURATION QUALITY MUNICIPAL TERM FUND
NIQ
-608
Closed -$8K
UNAM
4658
DELISTED
Unico American Corp
UNAM
$0 ﹤0.01%
40
-65
-62% -$391
DBD
4659
DELISTED
Diebold Nixdorf Incorporated
DBD
-5,480
Closed -$50K
BLCM
4660
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
-2,463
Closed -$42K
CYAD
4661
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
-1
Closed
NVCN
4662
DELISTED
Neovasc Inc.
NVCN
$0 ﹤0.01%
4
+1
+33% +$86
AGRX
4663
DELISTED
Agile Therapeutics
AGRX
-1
Closed -$3K
APEN
4664
DELISTED
Apollo Endosurgery, Inc.
APEN
$0 ﹤0.01%
100
-503
-83% -$1.59K
IUSS
4665
DELISTED
Invesco Exchange-Traded Self-Indexed Fund Trust Invesco RAFI Strategic US Small Company ETF
IUSS
$0 ﹤0.01%
+8
New +$185
QTT
4666
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$0 ﹤0.01%
12
-121
-91% -$5.11K
FSTX
4667
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
-1,507
Closed -$22K
SFT
4668
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$0 ﹤0.01%
+1
New +$99
OIIM
4669
DELISTED
02Micro International
OIIM
$0 ﹤0.01%
+111
New +$151
REED
4670
DELISTED
Reeds, Inc. Common Stock
REED
$0 ﹤0.01%
+9
New +$1.11K
HZN
4671
DELISTED
Horizon Global Corporation
HZN
-5,052
Closed -$18K
SJI
4672
DELISTED
South Jersey Industries, Inc.
SJI
-4,172
Closed -$141K
PRTY
4673
DELISTED
Party City Holdco Inc.
PRTY
$0 ﹤0.01%
72
-1,188
-94% -$6.78K
SPNE
4674
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$0 ﹤0.01%
36
-289
-89% -$3.49K
AATC
4675
DELISTED
Autoscope Technologies Corporation Common Stock
AATC
$0 ﹤0.01%
2
-3,343
-100% -$16.4K

Similar funds

Tower Research Capital (TRC)'s Q3 2019 Portfolio in Review

As of Q3 2019, Tower Research Capital (TRC) held 4,911 positions worth $1.46B, down 1.7% from $1.48B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC)'s Q3 2019 filing shows 1,154 new, 1,500 increased, 1,460 reduced and 679 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $119M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 4.3% a quarter earlier, followed by Financials and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2019 buy was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M.
  • Tower Research Capital (TRC) added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2019, an estimated $45.9M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $119M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2019, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $1.46B portfolio in Q3 2019.
  • Tower Research Capital (TRC) opened 1,154 new positions and closed 679 in Q3 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 1.7% quarter-over-quarter to $1.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2019, filed 5 Nov 2019.